Quick Takeaways
- Joseph K. Belanoff filed SCHEDULE 13G/A for Corcept Therapeutics Incorporated Common Stock (CORT).
- Disclosed ownership: 6.3%.
- Date of event: 31 Dec 2024.
Joseph K. Belanoff - 31 Dec 2024 SCHEDULE 13G/A Report for Corcept Therapeutics Incorporated Common Stock (CORT)
- Filing Manager
- Joseph K. Belanoff
- Reporting Manager
- Joseph K. Belanoff
- Symbol
- CORT
- Shares outstanding
- 108,291,032 shares
- Disclosed Ownership
- 6,822,335 shares
- Ownership
- 6.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 21:08:28 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Joseph K. Belanoff disclosed 6.3% ownership in Corcept Therapeutics Incorporated Common Stock (CORT) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 21:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Joseph K. Belanoff | 6.3% | 6,822,335 | 3,800,000 | 3,022,335 | /s/ Joseph K. Belanoff | Chief Executive Officer |